Olsen EA - Search Results

1

Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.

Olsen EA, Kim YH, Kuzel TM, Pacheco TR, Foss FM, Parker S, Frankel SR, Chen C, Ricker JL, Arduino JM, Duvic M. Olsen EA, et al. J Clin Oncol. 2007 Jul 20;25(21):3109-15. doi: 10.1200/JCO.2006.10.2434. Epub 2007 Jun 18. J Clin Oncol. 2007. PMID: 17577020 Clinical Trial.

2

Central nervous system involvement by cutaneous T cell lymphoma.

Grevelink SA, Fuller GN, Olsen EA. Grevelink SA, et al. Among authors: olsen ea. J Am Acad Dermatol. 1991 Sep;25(3):542-9. doi: 10.1016/0190-9622(91)70237-v. J Am Acad Dermatol. 1991. PMID: 1918492

3

Interferon alfa-2a in the treatment of cutaneous T cell lymphoma.

Olsen EA, Rosen ST, Vollmer RT, Variakojis D, Roenigk HH Jr, Diab N, Zeffren J. Olsen EA, et al. J Am Acad Dermatol. 1989 Mar;20(3):395-407. doi: 10.1016/s0190-9622(89)70049-9. J Am Acad Dermatol. 1989. PMID: 2783939 Clinical Trial.

4

Treatment of cutaneous T cell lymphoma with 2'-deoxycoformycin (pentostatin).

Dang-Vu AP, Olsen EA, Vollmer RT, Greenberg ML, Hershfield MS. Dang-Vu AP, et al. Among authors: olsen ea. J Am Acad Dermatol. 1988 Oct;19(4):692-8. doi: 10.1016/s0190-9622(88)70224-8. J Am Acad Dermatol. 1988. PMID: 3263401

5

Interferon in the treatment of cutaneous T-cell lymphoma.

Olsen EA, Bunn PA. Olsen EA, et al. Hematol Oncol Clin North Am. 1995 Oct;9(5):1089-107. Hematol Oncol Clin North Am. 1995. PMID: 8522486 Review.

6

Pentostatin (2'-deoxycoformycin) in the treatment of cutaneous T-cell lymphoma.

Greiner D, Olsen EA, Petroni G. Greiner D, et al. Among authors: olsen ea. J Am Acad Dermatol. 1997 Jun;36(6 Pt 1):950-5. doi: 10.1016/s0190-9622(97)80279-4. J Am Acad Dermatol. 1997. PMID: 9204061

7

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.

Olsen E, Duvic M, Frankel A, Kim Y, Martin A, Vonderheid E, Jegasothy B, Wood G, Gordon M, Heald P, Oseroff A, Pinter-Brown L, Bowen G, Kuzel T, Fivenson D, Foss F, Glode M, Molina A, Knobler E, Stewart S, Cooper K, Stevens S, Craig F, Reuben J, Bacha P, Nichols J. Olsen E, et al. J Clin Oncol. 2001 Jan 15;19(2):376-88. doi: 10.1200/JCO.2001.19.2.376. J Clin Oncol. 2001. PMID: 11208829 Clinical Trial.

8

Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.

Duvic M, Martin AG, Kim Y, Olsen E, Wood GS, Crowley CA, Yocum RC; Worldwide Bexarotene Study Group. Duvic M, et al. Arch Dermatol. 2001 May;137(5):581-93. Arch Dermatol. 2001. PMID: 11346336 Clinical Trial.

9

A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma.

Duvic M, Olsen EA, Omura GA, Maize JC, Vonderheid EC, Elmets CA, Shupack JL, Demierre MF, Kuzel TM, Sanders DY. Duvic M, et al. Among authors: olsen ea. J Am Acad Dermatol. 2001 Jun;44(6):940-7. doi: 10.1067/mjd.2001.113478. J Am Acad Dermatol. 2001. PMID: 11369904 Clinical Trial.

10

The role for interleukin-12 therapy of cutaneous T cell lymphoma.

Rook AH, Zaki MH, Wysocka M, Wood GS, Duvic M, Showe LC, Foss F, Shapiro M, Kuzel TM, Olsen EA, Vonderheid EC, Laliberte R, Sherman ML. Rook AH, et al. Among authors: olsen ea. Ann N Y Acad Sci. 2001 Sep;941:177-84. doi: 10.1111/j.1749-6632.2001.tb03721.x. Ann N Y Acad Sci. 2001. PMID: 11594571 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters